RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 6, 2003, Pages 1979-1983

  Giacometti, Andrea ^a   Cirioni, Oscar ^a   Gov, Yael ^d   Ghiselli, Roberto ^b   Del Prete, Maria Simona ^a   Mocchegiani, Federico ^b   Saba, Vittorio ^b   Orlando, Fiorenza ^c   Scalise, Giorgio ^a   Balaban, Naomi ^d   Dell'Acqua, Giorgio ^e  

^a Inst Infect Dis Pub Hlth U   (Italy)

^b INRCA   (Italy)

^c Research Department   (Italy)

^d TEL AVIV UNIVERSITY   (Israel)

^e Laboratoires Biologiques Arval SA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; DACRON; DALFOPRISTIN PLUS QUINUPRISTIN; HEPTAPEPTIDE; IMIPENEM; LEVOFLOXACIN; PSEUDOMONIC ACID; RIFAMPICIN; RNA; RNA III INHIBITING PEPTIDE; TEICOPLANIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BIOFILM; DACRON IMPLANT; HOSPITAL INFECTION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BIOFILMS; CELL COMMUNICATION; COLONY COUNT, MICROBIAL; DRUG SYNERGISM; MALE; MICROBIAL SENSITIVITY TESTS; OLIGOPEPTIDES; POLYETHYLENE TEREPHTHALATES; PROSTHESES AND IMPLANTS; RATS; RATS, WISTAR; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0037764090     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.6.1979-1983.2003     Document Type: Article

References (30)

1. Balaban, N., L. V. Collins, J. S. Cullor, E. B. Hume, E. Medina-Acosta, O. Vieira da Motta, R. O'Callaghan, P. V. Rossitto, M. E. Shirtliff, L. Serafim da Silveira, A. Tarkowski, and J. V. Torres. 2000. Prevention of diseases caused by Staphylococcus aureus using the peptide RIP. Peptides 21:1301-1311.
2. Balaban, N., A. Giacometti, O. Cirioni, Y. Gov, R. Ghiselli, F. Mocchegiani, C. Viticchi, M. S. Del Prete, V. Saba, G. Scalise, and G. Dell'Acqua. 2003. Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. J. Infect. Dis. 187:625-630.
3. Balaban, N., T. Goldkorn, Y. Gov, M. Hirshberg, N. Koyfman, H. R. Matthews, R. T. Nhan, B. Singh, and O. Uziel. 2001. Regulation of Staphylococcus aureus pathogenesis via target of RNAIII-activating protein (TRAP). J. Biol. Chem. 276:2658-2667.
4. Balaban, N., T. Goldkorn, R. T. Nhan, L. B. Dang, S. Scott, R. M. Ridgley, A. Rasooly, S. C. Wright, J. W. Larrick, R. Rasooly, and J. R. Carlson. 1998. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science 280:438-440.
5. Balaban, N., Y. Gov, A. Bitler, and J. R. Boelaert. 2003. The quorum sensing inhibitor RIP prevents adherence and biofilm formation of Staphylococcus aureus to human keratinocytes and dialysis catheters. Kidney Int. 63:340-345.
6. Barie, P. S. 1998. Antibiotic-resistant gram-positive cocci: implications for surgical practice. World J. Surg. 22:118-126.
7. Becker, P., W. Hufnagle, G. Peters, and M. Herrmann. 2001. Detection of differential gene expression in biofilm-forming versus planktonic populations of Staphylococcus aureus using micro-representational-difference analysis. Appl. Environ. Microbiol. 67:2958-2965.
8. Bergamini, T. M., J. C. Peyton, and W. G. Cheadle. 1992. Prophylactic antibiotics prevent bacterial biofilm graft infection. J. Surg. Res. 52:101-105.
9. Citak, M. S., J. I. Cue, J. C. Peyton, and M. A. Malangoni. 1992. The critical relationship of antibiotic dose and bacterial contamination in experimental infection. J. Surg. Res. 52:127-130.
10. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
11. Davies, D. G., M. R. Parsek, J. P. Pearson, B. H. Iglewski, J. W. Costerton, and E. P. Greenberg. 1998. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280:295-298.
12. Donlan, R. M., and J. W. Costerton. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
13. Ghiselli, R., A. Giacometti, L. Goffi, O. Cirioni, F. Mocchegiani, F. Orlando, A. M. Paggi, E. Petrelli, G. Scalise, and V. Saba. 2001. Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed Dacron. J. Surg. Res. 99:316-320.
14. Gottenbos, B., D. W. Grijpma, H. C. van der Mei, J. Feijen, and H. J. Busscher. 2001. Antimicrobial effects of positively charged surfaces on adhering gram-positive and gram-negative bacteria. J. Antimicrob. Chemother. 48:7-13.
15. Gov, Y., A. Bitler, G. Dell'Acqua, J. V. Torres, and N. Balaban. 2001. RNAIII inhibiting peptide (RIP), a global inhibitor of Staphylococcus aureus: structure and function analysis. Peptides 22:1609-1620.
16. Hartman, G., and R. Wise. 1998. Quorum sensing: potential means of treating gram-negative infections? Lancet 351:848-849.
17. Huebner, J., and D. A. Goldman. 1999. Coagulase-negative staphylococci: role as pathogens. Annu. Rev. Med. 50:233-236.
18. Ji, G., R. Beavis, and R. P. Novick. 1997. Bacterial interference caused by autoinducing peptide variants. Science 276:2027-2030.
19. Lina, G., S. Jarraud, G. Ji, T. Greenland, A. Pedraza, J. Etienne, R. P. Novick, and F. Vandenesch. 1998. Transmembrane topology and histidine protein kinase activity of AgrC, the agr signal receptor in Staphylococcus aureus. Mol. Microbiol. 28:655-662.
20. Marr, K. A. 2000. Staphylococcus aureus bacteremia in patients undergoing hemodialysis. Semin. Dial. 13:23-29.
21. Nassar, G. M., and J. C. Ayus. 2001. Infectious complications of the hemodialysis access. Kidney Int. 60:1-13.
22. National Committee for Clinical Laboratory Standards. 2001. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard. M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
23. Novick, R. P., H. F. Ross, S. J. Projan, J. Kornblum, B. Kreiswirth and S. Moghazeh. 1993. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 12:3967-3975.
24. Paradisi, F., G. Corti, and D. Messeri. 2001. Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibiotics. Med. Clin. N. Am. 85:1-17.
25. Pei, L., and J. I. Flock. 2001. Functional study of antibodies against a fibrinogen-binding protein in Staphylococcus epidermidis adherence to polyethylene catheters. J. Infect. Dis. 184:52-55.
26. Sher, K. S. 1997. Studies on the duration of antibiotic administration for surgical prophylaxis. Am. Surg. 63:59-62.
27. Smith, K. M., Y. Bu, and H. Suga. 2003. Induction and inhibition of Pseudomonas aeruginosa quorum sensing by synthetic autoinducer analogs. Chem. Biol. 10:81-89.
28. Stewart, P. S., and J. W. Costerton. 2001. Antibiotic resistance in biofilms. Lancet 358:135-138.
29. Tiller, J. C., C. J. Liao, K. Lewis, and A. M. Klibanov. 2001. Designing surfaces that kill bacteria on contact. Proc. Natl. Acad. Sci. USA 98:5981-5985.
30. Viera-da-Motta, O., P. D. Ribeiro, W. Dias da Silva, and E. Medina-Acosta. 2001. RNAIII inhibiting peptide (RIP) inhibits agr-regulated toxin production. Peptides 22:1621-1627.